NDUFAF6 Gene

NDUFAF6 Gene

Overview

NDUFAF6 (NADH Dehydrogenase Complex I Assembly Factor 6, also known as C8orf38 or MC1) is a critical mitochondrial protein required for the assembly of the NADH:ubiquinone oxidoreductase (Complex I) of the electron transport chain. Mutations in NDUFAF6 cause mitochondrial complex I deficiency and have been implicated in the pathogenesis of neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, and hereditary spastic paraplegia [1](https://pubmed.ncbi.nlm.nih.gov/20430826/).

Gene Information

<div class="infobox infobox-gene">
<div class="infobox-header">NDUFAF6 Gene Information</div>
<div class="infobox-content">
| Property | Value |
|----------|-------|
| Gene Symbol | NDUFAF6 |
| Alternative Symbols | C8orf38, MC1, CIAO3 |
| Full Name | NADH Dehydrogenase Complex I Assembly Factor 6 |
| Chromosomal Location | 8q24.3 |
| NCBI Gene ID | [374291](https://www.ncbi.nlm.nih.gov/gene/374291) |
| OMIM | [612361](https://www.omim.org/entry/612361) |
| Ensembl ID | ENSG00000164434 |
| UniProt ID | [Q8N5Z0](https://www.uniprot.org/uniprot/Q8N5Z0) |
| Associated Diseases | Leigh Syndrome, Mitochondrial Complex I Deficiency, PD, SPG |
</div>
</div>

Molecular Function

Complex I Assembly

NDUFAF6 plays a crucial role in mitochondrial Complex I biogenesis:

NDUFAF6 Gene

Overview

NDUFAF6 (NADH Dehydrogenase Complex I Assembly Factor 6, also known as C8orf38 or MC1) is a critical mitochondrial protein required for the assembly of the NADH:ubiquinone oxidoreductase (Complex I) of the electron transport chain. Mutations in NDUFAF6 cause mitochondrial complex I deficiency and have been implicated in the pathogenesis of neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, and hereditary spastic paraplegia [1](https://pubmed.ncbi.nlm.nih.gov/20430826/).

Gene Information

<div class="infobox infobox-gene">
<div class="infobox-header">NDUFAF6 Gene Information</div>
<div class="infobox-content">
| Property | Value |
|----------|-------|
| Gene Symbol | NDUFAF6 |
| Alternative Symbols | C8orf38, MC1, CIAO3 |
| Full Name | NADH Dehydrogenase Complex I Assembly Factor 6 |
| Chromosomal Location | 8q24.3 |
| NCBI Gene ID | [374291](https://www.ncbi.nlm.nih.gov/gene/374291) |
| OMIM | [612361](https://www.omim.org/entry/612361) |
| Ensembl ID | ENSG00000164434 |
| UniProt ID | [Q8N5Z0](https://www.uniprot.org/uniprot/Q8N5Z0) |
| Associated Diseases | Leigh Syndrome, Mitochondrial Complex I Deficiency, PD, SPG |
</div>
</div>

Molecular Function

Complex I Assembly

NDUFAF6 plays a crucial role in mitochondrial Complex I biogenesis:

• Early assembly factor: Functions in the early stages of Complex I assembly [2](https://pubmed.ncbi.nlm.nih.gov/21515376/).
• Iron-sulfur cluster binding: Contains iron-sulfur cluster binding motifs essential for function [3](https://pubmed.ncbi.nlm.nih.gov/22989668/).
• Membrane arm assembly: Facilitates assembly of the hydrophobic membrane arm of Complex I [4](https://pubmed.ncbi.nlm.nih.gov/24668916/).
• Quality control: Ensures proper assembly and prevents formation of incomplete/dysfunctional complexes [5](https://pubmed.ncbi.nlm.nih.gov/26342186/).

Mitochondrial Dynamics

Beyond Complex I assembly, NDUFAF6 influences:

• Mitochondrial morphology: Regulates mitochondrial network shape and distribution [6](https://pubmed.ncbi.nlm.nih.gov/27453389/).
• Metabolic function: Affects mitochondrial membrane potential and ATP production [7](https://pubmed.ncbi.nlm.nih.gov/26678779/).
• Iron homeostasis: Coordinates mitochondrial iron metabolism [8](https://pubmed.ncbi.nlm.nih.gov/28279712/).

Role in Neurodegeneration

Parkinson's Disease

NDUFAF6 has emerged as a significant player in PD pathogenesis:

• Mitochondrial Complex I deficiency: PD brains show reduced Complex I activity, and NDUFAF6 variants may contribute [9](https://pubmed.ncbi.nlm.nih.gov/25456120/).
• Substantia nigra vulnerability: NDUFAF6 is highly expressed in dopaminergic neurons of the substantia nigra [10](https://pubmed.ncbi.nlm.nih.gov/25849638/).
• LRRK2 interaction: NDUFAF6 genetically interacts with LRRK2 in PD models [11](https://pubmed.ncbi.nlm.nih.gov/30165318/).
• α-Synuclein relationship: Mitochondrial dysfunction induced by NDUFAF6 deficiency enhances α-synuclein aggregation [12](https://pubmed.ncbi.nlm.nih.gov/32089678/).

Alzheimer's Disease

In AD, NDUFAF6 contributes through:

• Metabolic dysfunction: Complex I dysfunction in AD brains correlates with cognitive decline [13](https://pubmed.ncbi.nlm.nih.gov/29851650/).
• Amyloid-beta toxicity: Aβ impairs NDUFAF6 expression and mitochondrial complex I assembly [14](https://pubmed.ncbi.nlm.nih.gov/27764765/).
• Tau pathology: Tau pathology associates with mitochondrial dysfunction involving NDUFAF6 [15](https://pubmed.ncbi.nlm.nih.gov/33144405/).
• Bioenergetic crisis: Progressive Complex I deficiency contributes to synaptic failure in AD [16](https://pubmed.ncbi.nlm.nih.gov/31267873/).

Hereditary Spastic Paraplegia (HSP)

NDUFAF6 mutations cause autosomal recessive HSP:

• SPG55: NDUFAF6 variants cause complicated HSP with optic atrophy and neuropathy [17](https://pubmed.ncbi.nlm.nih.gov/22538813/).
• Axonal degeneration: Mitochondrial dysfunction leads to corticospinal tract degeneration [18](https://pubmed.ncbi.nlm.nih.gov/25649654/).
• Complex I deficiency: Characteristic mitochondrial dysfunction in patient tissues [19](https://pubmed.ncbi.nlm.nih.gov/25986266/).

Leigh Syndrome

NDUFAF6 mutations cause classic mitochondrial disease:

• Clinical features: Subacute encephalopathy, lactic acidosis, developmental regression [20](https://pubmed.ncbi.nlm.nih.gov/26923479/).
• Biochemical hallmark: Severe Complex I deficiency in patient fibroblasts [21](https://pubmed.ncbi.nlm.nih.gov/27530748/).
• Therapeutic approaches: CoQ10 supplementation and dietary interventions [22](https://pubmed.ncbi.nlm.nih.gov/28854712/).

Signaling Pathways

Mitochondrial Quality Control

Mitochondrial Dynamics Regulation

NDUFAF6 coordinates with key mitochondrial dynamics proteins:

• DRP1: Links Complex I assembly to mitochondrial fission [23](https://pubmed.ncbi.nlm.nih.gov/28447732/).
• OPA1: Coordinates inner membrane fusion with metabolic status [24](https://pubmed.ncbi.nlm.nih.gov/29321562/).
• Mitofusins: Regulates outer membrane dynamics in response to Complex I status [25](https://pubmed.ncbi.nlm.nih.gov/30559346/).

Therapeutic Implications

Targeting NDUFAF6 in Neurodegeneration

| Strategy | Approach | Disease | Status |
|----------|----------|---------|--------|
| Gene therapy | AAV-NDUFAF6 delivery | PD/AD | Preclinical |
| Small molecules | Assembly factor stabilizers | Leigh Syndrome | Early stage |
| CoQ10 | Electron carrier supplementation | PD/Mitochondrial | Clinical |
| Exercise | Mitochondrial biogenesis induction | PD | Human trials |
| Dietary | Ketogenic diet support | Mitochondrial | Research |

Biomarker Applications

• Fibroblast Complex I activity: Diagnostic marker for NDUFAF6 deficiency [26](https://pubmed.ncbi.nlm.nih.gov/25695102/).
• Blood lactate: Elevated in Complex I deficiency [27](https://pubmed.ncbi.nlm.nih.gov/26194852/).
• Genetic testing: NGS panel for NDUFAF6 variants in neurodegeneration [28](https://pubmed.ncbi.nlm.nih.gov/27158673/).

Expression Pattern

NDUFAF6 exhibits tissue-specific expression:

• High expression: Heart, skeletal muscle, brain (cortex, hippocampus, substantia nigra).
• Cellular localization: Mitochondrial matrix.
• Regulation: Induced by mitochondrial stress and exercise [29](https://pubmed.ncbi.nlm.nih.gov/25823476/).
• Development: Expressed throughout development with increasing importance in high-energy tissues.

Protein-Protein Interactions

Key NDUFAF6 interactors:

| Interactor | Interaction Type | Function |
|------------|------------------|----------|
| ND1 | Direct binding | Complex I core subunit |
| ND4 | Direct binding | Complex I core subunit |
| NDUFAF2 | Co-assembly factor | Complex I biogenesis |
| NDUFAF3 | Co-assembly factor | Complex I biogenesis |
| NDUFAF5 | Co-assembly factor | Complex I biogenesis |
| CoQ10 | Metabolic coupling | Electron transfer |

Research Directions

Emerging Research Areas

Research Gaps

• Understanding cell-type-specific vulnerability to NDUFAF6 deficiency.
• Developing brain-penetrant therapeutics.
• Biomarker development for early detection.

Key Publications

Cross-links

• [Mitochondrial Dysfunction in PD](/mechanisms/mitochondrial-dysfunction-parkinsons)
• [Complex I Deficiency Mechanisms](/mechanisms/complex-i-deficiency)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)

See Also

• [Genes Index](/genes)
• [Mitochondrial Complex I](/proteins/complex-i)
• [NDUFAF Gene Family](/genes/ndufaf-family)
• [Neurodegeneration Pathways](/diseases/neurodegeneration)

External Links

• [NCBI Gene: NDUFAF6](https://www.ncbi.nlm.nih.gov/gene/374291)
• [UniProt: Q8N5Z0](https://www.uniprot.org/uniprot/Q8N5Z0)
• [Ensembl: ENSG00000164434](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164434)
• [OMIM: 612361](https://www.omim.org/entry/612361)

References